Ilya Shestopalov

Ilya Shestopalov leads the Analytical Development function at Tessera Therapeutics. Prior to Tessera, Ilya led Analytical Development at bluebird bio, contributing to development and approval of Zynteglo, Lyfgenia, Skysona, and Abecma. Ilya has a PhD in Organic Chemistry from Stanford University and did a postdoctoral fellowship in Stem Cell biology at Harvard University.